Hankang Capital Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 95

  • Portfolio
  • 41

  • Exits
  • 23

Exits

Hankang Capital General Information

Company Description

Founded in 2010, Hankang Capital is a venture capital arm of Zhongjianxin Group based in Shanghai, China. The firm focuses on making investments in sectors like biomedicine, medical equipment, diagnostic reagents, medical services and other major health fields.

Business Details

Website
www.jianxincapital.com
Formerly Known As
Jianxin Kangying Ventures, Jianxin Ventures, Jianxin Kaiying Venture Capital, Shanghai Jianxin Equity Investment Management Co., Ltd., Jianxin Capital, Shanghai Jianxin Capital
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Other Investor Types
Corporate Venture Capital
Corporate Office
  • Unit 02, 60th Floor, Qiantan Center
  • Number 555 Haiyang West Road, Pudong New Area
  • Shanghai
  • China
+86 180

Hankang Capital Investments (95)

Hankang Capital’s most recent investment was a with AusperBio for . The deal was made on 27-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AusperBio 27-Aug-2026 Drug Discovery Generating Revenue
VIVACTA Biotechnology 13-Apr-2026 Drug Discovery Generating Revenue
Pinnacle Medicines 26-Mar-2026 Drug Discovery Generating Revenue
SciBrunch Therapeutics 30-Jan-2026 Drug Discovery Generating Revenue
VIVACTA Biotechnology 26-Jan-2026 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 5 of 95 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hankang Capital Exits (23)

Hankang Capital has made a total of 23 exits. Its latest exit was from Bestudy on 20-Mar-2026. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Bestudy 20-Mar-2026
Phrontline Biopharma 19-Dec-2025
Leads Biolabs 25-Jul-2025
AnchorDx 04-Dec-2024
Donglei Brain Hospital 28-Nov-2023 Secondary Transaction - Private
You’re viewing 5 of 23 exits. Get the full list »

Hankang Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Hankang Capital FAQs

  • What is Hankang Capital?

    Founded in 2010, Hankang Capital is a venture capital arm of Zhongjianxin Group based in Shanghai, China.

  • When was Hankang Capital founded?

    Hankang Capital was founded in 2010.

  • Where is Hankang Capital headquartered?

    Hankang Capital is headquartered in Shanghai, China.

  • What is Hankang Capital's total asset value?

    Hankang Capital has around in total assets under management.

  • How many investments has Hankang Capital made?

    Hankang Capital has made 95 investments.

  • What has Hankang Capital invested in?

    Hankang Capital has made numerous investments in companies like AusperBio, VIVACTA Biotechnology, and Pinnacle Medicines within the Drug Discovery industry.

  • What has Hankang Capital invested in recently?

    Hankang Capital's latest investment was on 27-Aug-2026 in AusperBio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process